US-based biotech firm Cibus is taking steps towards an initial public offering (IPO), as part of its plans for future expansion. The canola seed developer has filed paperwork related to a proposed IPO with the US Securities and Exchange Commission. While details regarding the price range and number of shares that will be offered have not yet been disclosed, Cibus is intending to list on the Nasdaq, with Morgan Stanley and BofA Merrill Lynch expected to act as book-running managers.
California-based biotech firm Cibus is taking steps towards an initial public offering (IPO), as part of its plans for future expansion. The canola seed developer has filed paperwork related to a proposed IPO with the US Securities and Exchange Commission. While details regarding the price range and number of shares that will be offered have not yet been disclosed, Cibus is intending to list on the Nasdaq, with Morgan Stanley and BofA Merrill Lynch expected to act as book-running managers.